(210) | Number of the EPO application | 17853220 |
(220) | Filing date of the EPO application | 2017.09.26 |
(80) | EPO patent specification publication (B) | EPB nr. 11/2024, 2024.03.13 |
(110) | EPO patent number | 3517538 |
(11) | Number of the document | MD 3517538 T2 |
(21) | Number of the application | e 2019 0833 |
(71) | Name(s) of applicant(s), code of the country | CHUGAI SEIYAKU KABUSHIKI KAISHA, JP; |
(72) | Name(s) of inventor(s), code of the country | YOSHINO Hitoshi, JP; TSUCHIYA Satoshi, JP; MATSUO Atsushi, JP; SATO Tsutomu, JP; NISHIMOTO Masahiro, JP; OGURI Kyoko, JP; OGAWA Hiroko, JP; NISHIMURA Yoshikazu, JP; FURUTA Yoshiyuki, JP; KASHIWAGI Hirotaka, JP; HORI Nobuyuki, JP; KAMON Takuma, JP; SHIRAISHI Takuya, JP; YOSHIDA Shoshin, JP; KAWAI Takahiro, JP; TANIDA Satoshi, JP; AOKI Masahide, JP; |
(73) | Name(s) of owner(s), code of the country | CHUGAI SEIYAKU KABUSHIKI KAISHA, JP; |
(54) | Title of the invention | Pyrazolopyridine derivative having GLP-1 receptor agonist effect |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | C07D 471/04 (2006.01.01); A61K 31/437 (2006.01.01); A61K 31/444 (2006.01.01); A61K 31/4709 (2006.01.01); A61K 31/4725 (2006.01.01); A61K 31/496 (2006.01.01); A61K 31/506 (2006.01.01); A61K 31/5377 (2006.01.01); A61K 31/5386 (2006.01.01); A61P 1/16 (2006.01.01); A61P 3/04 (2006.01.01); A61P 3/06 (2006.01.01); A61P 3/10 (2006.01.01); A61P 9/10 (2006.01.01); A61P 25/16 (2006.01.01); A61P 25/28 (2006.01.01); C07D 519/00 (2006.01.01) |
(19) | Country | JP |
(41) | Date of publication of the application | 2019.09.30 |
(49) | Date of publication of the translation of the validated European patent specification | 2024.09.30 |
(30) | Priority | 2016187605, 2016.09.26, JP |
(74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
(86) | International application | PCT/JP2017/034620, 2017.09.26 |
(87) | International publication | WO 2018/056453, 2018.03.29 |